Identification of the active component that induces vancomycin resistance in MRSA
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-09-25
著者
-
IWATSUKI Masato
The Kitasato Institute
-
HANAKI Hideaki
Laboratory of Infectious Diseases, Graduate School of Infection Control Sciences, Kitasato Universit
-
MATSUI Hidehito
Kitasato Research Center for Anti-infection Drugs
-
SUNAKAWA Keisuke
Graduate School of Infection Sciences, Kitasato University
-
Sunakawa Keisuke
Institute For Clinical Research National Hospital Organization Tochigi Hospital
-
Nakae Taiji
Research Center For Anti-infective Drugs The Kitasato Institute
-
Yanagisawa Chie
Kitasato University Research Center For Anti-infectious Drugs
-
Sunakawa Keisuke
Laboratory Of Infectious Disease Graduate School Of Infection Control Sciences Kitasato University
-
Suzuki Kunihiko
Research Center For Biological Function The Kitasato Institute And Pharmaceutical Sciences Kitasato
-
Omura Satoshi
Kitasato Institute For Life Sciences And Graduate School Of Infection Control Sciences Kitasato Univ
-
Isozaki Miki
Kitasato Institute For Life Sciences Kitasato University
-
Shiomi K
Kitasato Institute For Life Sciences And Graduate School Of Infection Control Sciences Kitasato Univ
-
Ikeda Dantsuji
Kitasato University Research Center For Anti-infectious Drugs
-
Ikeda Dantsuji
Research Center For Anti-infectious Drugs And Kitasato Institute For Life Sciences Kitasato Universi
-
Yanagisawa Chie
Research Center For Anti-infectious Drugs Kitasato University
-
Sugiyama Kenji
Laboratory Of Infectious Diseases Science Graduate School Of Infection Control Science Kitasato Univ
-
Hanaki Hideaki
The Kitasato University
-
Shiomi Kazuro
Research Center For Biological Function The Kitasato Institute And School Of Pharmaceutical Sciences
-
Sunakawa Keisuke
Laboratory Of Infectious Diseases Science Graduate School Of Infection Control Science Kitasato Univ
-
Omura Satoshi
School Of Pharmaceutical Sciences Kitasato University:research Center For Biological Function The Ki
-
Iwatsuki Masato
Kitasato Institute For Life Sciences Kitasato University
-
Ito Minako
Research Center For Biological Function The Kitasato Institute
-
Sunakawa Keisuke
Japanese Society Of Chemotherapy
-
Sunakawa Keisuke
Kitasato University Kitasato Institute For Life Sciences
-
SHIOMI Kazuro
Graduate School of Infection Control Sciences, Kitasato University
-
IKEDA Shinsuke
Graduate School of Infection Control Sciences, Kitasato University
-
YANAGISAWA Chie
Laboratory for Antimicrobial Agents, Kitasato University
-
IKEDA DANTSUJI
Laboratory for Antimicrobial Agents, Kitasato University
-
MATSUI Hidehito
Laboratory for Antimicrobial Agents, Kitasato University
-
NAKAE Taiji
Laboratory for Antimicrobial Agents, Kitasato University
-
Matsui Hidehito
Laboratory For Antimicrobial Agents Kitasato University
-
Ikeda Shinsuke
Graduate School Of Infection Control Sciences Kitasato University
-
Omura Satoshi
Kitasato Institute
関連論文
- Study of nasopharyngeal bacterial flora. Variations in nasopharyngeal bacterial flora in schoolchildren and adults when administered antimicrobial agents
- Study of nasopharyngeal bacterial flora. Second report. Variations in nasopharyngeal bacterial flora in children aged 6 years or younger when administered antimicrobial agents. Part 2
- Study of nasopharyngeal bacterial flora. Second report. Variations in nasopharyngeal bacterial flora in children aged 6 years or younger when administered antimicrobial agents. Part 1
- Study of upper respiratory tract bacterial flora : first report. Variations in upper respiratory tract bacterial flora in patients with acute upper respiratory tract infection and healthy subjects and variations by subject age
- Biochemical and Spectroscopic Properties of Cyanide-Insensitive Quinol Oxidase from Gluconobacter oxydans
- Guadinomines, Type III Secretion System Inhibitors, Produced by Streptomyces sp. K01-0509 : II. Physico-chemical Properties and Structure Elucidation
- Guadinomines, Type III Secretion System Inhibitors, Produced by Streptomyces sp. K01-0509 : I. Taxonomy, Fermentation, Isolation and Biological Properties
- PHARMACOKINETICS AND CLINICAL EFFECTS OF CEFOZOPRAN IN PEDIATRIC PATIENTS
- Differentiation of β-lactamase-negative ampicillin-resistant Haemophilus influenzae from other H. influenzae strains by a disc method
- Characterization of β-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration
- Trends of β-lactam antibiotic susceptibility in blood-borne methicillin-resistant Staphylococcus aureus (MRSA) and their linkage to the staphylococcal cassette chromosome mec (SCCmec) type
- Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes
- Nosocomial infection of β-lactam antibiotic-induced vancomycin-resistant Staphylococcus aureus (BIVR)
- Investigation of β-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR)
- Lariatins, Novel Anti-mycobacterial Peptides with a Lasso Structure, Produced by Rhodococcus jostii K01-B0171
- Substrate specificity of HMRZ-86 for β-lactamases, including extended-spectrum β-lactamases (ESBLs)
- Inhibitory Effect of Bifidobacteria on the In Vitro Production of Verotoxins by Escherichia coli O157:H7
- Terpendoles, Novel ACAT Inhibitors Produced by Albophoma yamanashiensis II.Structure Elucidation of Terpendoles A, B, C and D
- Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR
- Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia
- Rapid optimization of antimicrobial chemotherapy given to pediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture
- In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance
- Kurasoins A and B, New Protein Farnesyltransferase Inhibitors Produced by Paecilomyces sp. FO-3684 I. Producing Strain, Fermentation, Isolation, and Biological Activities
- Andrastins A-S, New Protein Farnesyltransferase Inhibitors Produced by Penicillium sp. F)-3929 I. producing Strain, Fermentation, Isolation, and Biological Activities
- Herquline B, a New Platelet Aggregation Inhibitor Produced by Penicillium herquei Fg-372
- Isochromophilones III~VI, Inhibitors of Acyl-CoA:Cholesterol Acyltransferase Produced by Penicillium multicolor FO-3216
- A New Anti-influenza Virus Antibiotic, 10-Norparvulenone from Microsphaeropsis sp. FO-5050
- A New Antimicrobial Antibiotic from Actinoplanes capillaceus sp. K95-5561^T
- Phenopyrrozin, a New Radical Scavenger Produced by Penicillium sp.FO-2047
- New Glycosidases Inhibitors, Panosialins D and wD Produced by StreptOmyces sp.OH-5186
- Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin
- Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan
- Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus : a new type of MRSA
- Polymyxin B Identified as an Inhibitor of Alternative NADH Dehydrogenase and Malate : Quinone Oxidoreductase from the Gram-positive Bacterium Mycobacterium smegmatis
- Siccanin Rediscovered as a Species-Selective Succinate Dehydrogenase Inhibitor
- Verticipyrone, a New NADH-fumarate Reductase Inhibitor, Produced by Verticillium sp. FKI-1083
- Paecilaminol, a New NADH-Fumarate Reductase Inhibitor, Produced by Paecilomyces sp. FKI-0550
- Aγ-Lactone Form Nafuredin, Nafuredin-γ, also Inhibits Helminth Complex I
- Isolation of a New Antibiotic Oligomycin G Produced by Streptomyces sp. WK-6150
- Antimalarial Activity of Radicicol, Heptelidic Acid and Other Fungal Metabolites
- Two New Components of the Aspochalasins Produced by Aspergillus sp.
- Enhancement of Drug Accumulation by Andrastin A Produced by Penicillium sp. FO-3929 in Vincristine-resistant KB Cells
- Amphistin, a New Melanogenesis Inhibitor, Produced by an Actinomycete
- Argadin, a New Chitinase Inhibitor, Produced by Clonostachys sp.FO-7314
- Argifin, a New Chitinase Inhibitor, Produced by Gliocladium sp. FTD-0668 : I. Taxonomy, Fermentation, and Biological Activities
- In vitro protein binding of teicoplanin to neonatal serum
- Septicemia in the Neonatal Intensive Care Unit Over the Past 15 Years
- Cyslabdan, a New Potentiator of Imipenem Activity against Methicillin-resistant Staphylococcus aureus, Produced by Streptomyces sp. K04-0144 : II. Biological Activities
- Cyslabdan, a New Potentiator of Imipenem Activity against Methicillin-resistant Staphylococcus aureus, Produced by Streptomyces sp. K04-0144 : I. Taxonomy, Fermentation, Isolation and Structural Elucidation
- Fungal Phenalenones Inhibit HIV-1 Integrase
- Yaequinolones, New Insecticidal Antibiotics Produced by Penicillium sp. FKI-2140 : I. Taxonomy, Fermentation, Isolation and Biological Activity
- New Insecticidal Antibiotics, Hydroxyfungerins A and B, Produced by Metarhizium sp. FKI-1079
- New Sesquicillins, Insecticidal Antibiotics Produced by Albophoma sp. FKI-1778
- New Antibiotics Miyakamides Produced by a Fungus
- In Vitro and in Vivo Antitrypanosomal Activitiy of Two Microbial Metabolites, KS-505a and Alazopeptin
- Effect of 14-Membered Ring Macrolide Compounds on Rat Leucocyte Chemotaxis and the Structure-activity Relationships
- Effcects of Erythromycin and Its Derivatives on Interlcukin-8 Release by Human Bronchial Epithelial Cell Line BEAS-2B Cells
- Nationwide survey of the development of drug-resistance in the pediatric field : drug sensitivity of Haemophilus influenzae in Japan
- Nationwide survey of the development of drug-resistant pathogens in the pediatric field : drug sensitivity of Streptococcus pneumoniae in Japan
- Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid
- A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients
- Inhibitory Effect of the Oral Administration of Bifidobacteria on Norfloxacin-Induced Verotoxin Production in Germ-Free Mice Infected with Escherichia coli O157:H7
- P-468 A Novel Ryanodine Binding Inhibitor, Verticilide, Produced by Verticilium sp. FKI-1033
- A New Antibiotic, Antimycin A_9, Produced by Streptomyces sp. K01-0031
- Andrastins A-C, New Protein Farnesyltransferase Inhibitors Produced by Penicillium sp. FO-3929 II. Structure Elucidation and Biosynthesis
- Selective and Potent in Vitro Antitrypanosomal Activities of Ten Microbial Metabolites
- In Vitro Antimalarial Activities of the Microbial Metabolites
- Potent Antimalarial Activities of Polyether Antibiotic, X-206
- Funalenone, a Novel Collagenase Inhibitor Produced by Aspergillus niger
- Novel Cyclopentanone Derivatives Pentenocins A and B, with Interleukin-1βConverting Enzyme Inhibitory Activity, Produced by Trichoderma hamatum FO-6903
- P-490 Total synthesis of (+)-guadinomines C, potent, selective inhibitors of Type III secretion system. Determination of the absolute configurations
- The Synthesis of 7-Substituted-3-dinitrostyryl Cephalosporins and Their Ability for Detecting Extended Spectrum β-Lactamases (ESBLs)
- The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy
- Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan
- Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan
- Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008 : general view of the pathogens' antibacterial susceptibility
- Trends in empirical chemotherapy of bacterial meningitis in children aged more than 4 months in Japan : a survey from 1997 through 2008
- Molecular epidemiologic characteristics of Streptococcus pneumoniae isolates from children with meningitis in Japan from 2007 through 2009
- Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia
- Penicillium viticola, a new species isolated from a grape in Japan
- In vitro antitrypanosomal activity of some phenolic compounds from propolis and lactones from Fijian Kawa (Piper methysticum)
- In vitro antitrypanosomal activity of bis(bibenzyls)s and bibenzyls from liverworts against Trypanosoma brucei
- Spoxazomicins A-C, novle antitrypanosomal alkaloids produced by an endophytic actinomycete, Streptosporangium oxazolinicum K07-0460^T
- Panowamycins A and B, new antitrypanosomal isochromans produced by Streptomyces sp. K07-0010
- Enhancement of metabolites productivity of Penicillium pinophilum FKI-5653, by co-culture with Trichoderma harzianum FKI-5655
- Borrelidin, a potent antimalarial : stage-specific inhibition profile of synchronized cultures of Plasmodium falciparum
- A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium
- In vitro and in vivo antimalarial activity of puberulic acid and its new analogs, viticolins A-C, produced by Penicillium sp. FKI-4410
- In vitro antitrypanosomal activity of five low-MW antibiotics
- In vitro and in vivo anti-Trypanosoma brucei activities of phenazinomycin and related compounds
- Promising lead compounds for novel antiprotozoals
- Jogyamycin, a new antiprotozoal aminocyclopentitol antibiotic, produced by Streptomyces sp. a-WM-JG-16.2
- Sinefungin VA and dehydrosinefungin V, new antitrypanosomal antibiotics produced by Streptomyces sp. K05-0178
- In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships
- Virgaricin produced by Virgaria sp. FKI-4860
- In vitro and in vivo antiprotozoal activities of bispolides and their derivatives
- Identification of the active component that induces vancomycin resistance in MRSA
- Pyrenocine I, a new pyrenocine analog produced by Paecilomyces sp. FKI-3573
- Antitrypanosomal peptaibiotics, trichosporins B-VIIa and B-VIIb, produced by Trichoderma polysporum FKI-4452
- Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6')/APH(2")